Beta Bionics (BBNX) Revenue & Revenue Breakdown
Beta Bionics Revenue Highlights
Latest Revenue (Y)
$65.12M
Latest Revenue (Q)
$23.24M
Beta Bionics Revenue by Period
Beta Bionics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $65.12M | 442.93% |
| 2023-12-31 | $11.99M | 6601.12% |
| 2022-12-31 | $179.00K | - |
Beta Bionics generated $65.12M in revenue during NA 2024, up 442.93% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Beta Bionics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $23.24M | 31.74% |
| 2025-03-31 | $17.64M | -13.70% |
| 2024-12-31 | $20.44M | 22.36% |
| 2024-09-30 | $16.70M | 11.03% |
| 2024-06-30 | $15.05M | 16.34% |
| 2024-03-31 | $12.93M | 54.89% |
| 2023-12-31 | $8.35M | 169.96% |
| 2023-09-30 | $3.09M | - |
Beta Bionics generated $23.24M in revenue during Q2 2025, up 31.74% compared to the previous quarter, and up 179.68% compared to the same period a year ago.
Beta Bionics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| EVH | Evolent Health | $2.55B | $444.33M |
| TNDM | Tandem Diabetes Care | $940.20M | $234.42M |
| CTEV | Claritev | $930.62M | $241.57M |
| PCRX | Pacira BioSciences | $700.97M | $181.10M |
| ANAB | AnaptysBio | $91.28M | $27.77M |
| BBNX | Beta Bionics | $65.12M | $23.24M |
| TNGX | Tango Therapeutics | $42.07M | $3.18M |
| PGEN | Precigen | $3.92M | $856.00K |
| PROK | ProKidney | $76.00K | $221.00K |
| BCAX | Bicara Therapeutics | - | - |
| MNMD | Mind Medicine (MindMed) | - | - |